VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC:FITY) today issues the following clarification ...

Revenue estimates for Standard BioTools Inc (NASDAQ:LAB) have remained steady at $171.20 million for the full year 2024. However, they have declined from $188.17 million to $186.93 million for 2025 ...

An update from Innovotech ( ($TSE:IOT) ) is now available. Innovotech Inc. has consolidated its two wholly owned subsidiaries, Innovotech Labs ...

LAB is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of LAB shares has decreased $0.01 since the market last closed. This is a 0.78% ...

Rocket Lab, Micron, Sandisk, and CoreWeave led last week's large-cap rally—alongside Lumentum, Venture Global, Astera Labs, ...

Good day and welcome to the Standard BioTools, Inc., First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EAG, Inc. (Evans Analytical Group), the world’s leading, fully integrated, independent laboratory network, providing high value expert analytical and testing ...

Learn more about whether Zai Lab Limited or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

SAN FRANCISCO, July 26, 2021 /PRNewswire/ -- The global lab automation market size is expected toreach USD 8.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is ...

Learn more about whether Charles River Laboratories International, Inc. or West Pharmaceutical Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' ...

Standard BioTools Inc (NASDAQ:LAB) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $40.10 million, and the earnings are expected to come in at ...

Standard BioTools Inc. (LAB) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.